Clinical trial · Interventional
Quality Control of Esophagogastroduodenoscopy Using Real-time EGD Auxiliary System
Utilization of Real-time Automatic Quality-control System in the Detection of Gastric Neoplasms
NCT03883035CI-TRIAL-00043100completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of our study was to develop an automatic quality-control system and assess the performance of this system in quality control of esophagogastroduodenoscopy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Esophagogastroduodenoscopy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| automatic quality-control system | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- EAS-aided group
- description
- esophagogastroduodenoscopy examination with the assistance of automatic quality-control system
- interventionNames
- Other: automatic quality-control system
- type
- NO_INTERVENTION
- label
- control group
- description
- conventional standard esophagogastroduodenoscopy examination without the assistance of automatic quality-control system
Primary outcomes (1)
- measure
- detection rate of gastric neoplasms
- timeFrame
- 8 months
- description
- detection rate of gastric neoplasms in different groups
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 40 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * patients undergoing EGD examination with anaesthesia; * patients able to give informed consent. Exclusion Criteria: * patients with the contraindications to EGD examination; * patients with a prior EGD examination within 1 year before the trial; * patients with frankly upper gastrointestinal malignant lesions that were apparent on endoscopy; * a history of upper gastrointestinal cancers; * allergic to anaesthetic in previous medical history; * patients refused to participate in the trial; * the EGD procedure cannot be completed due to stenosis, obstruction, solid food, or complications of anaesthesia.
References
Publications (0)
Data not yet available
No reference posted for this study.